First-line anticancer drugs in patients with advanced, primary Non-Small Cell Lung Cancer: drug-utilization and effectiveness studies from Tuscany Region healthcare database

First published 08/08/2020

Last updated 08/08/2020

EU PAS number:

EUPAS36692

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

200808_Encepp_First-line_NSCLC

English (2.18 MB - PDF) View document

Study results

No information provided.

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

First-line anticancer drugs in patients with advanced, primary Non-Small Cell Lung Cancer: drug-utilization and effectiveness studies from Tuscany Region healthcare database

Secondary tabs

Share this page